Department of Epidemiology, School of Public Health, Southern Medical University, and Department of Public Health and Preventive Medicine, School of Medicine, Jinan University, Guangzhou, China (D.L.).
Department of Epidemiology, School of Public Health, Southern Medical University, Guangzhou, China (Z.L., D.S., P.Z., W.S., W.Z., Q.H., P.C., X.Z.).
Ann Intern Med. 2022 Jul;175(7):909-917. doi: 10.7326/M21-2977. Epub 2022 May 31.
Previous observational studies have suggested an association between coffee intake and reduced risk for death, but these studies did not distinguish between coffee consumed with sugar or artificial sweeteners and coffee consumed without.
To evaluate the associations of consumption of sugar-sweetened, artificially sweetened, and unsweetened coffee with all-cause and cause-specific mortality.
Prospective cohort study.
Data were extracted from the UK Biobank.
A total of 171 616 participants (mean age, 55.6 years [SD, 7.9]) without cardiovascular disease (CVD) or cancer at baseline were eligible. Baseline demographic, lifestyle, and dietary data from the UK Biobank were used, with follow-up beginning in 2009 and ending in 2018.
Dietary consumption of sugar-sweetened, artificially sweetened, and unsweetened coffee was self-reported. All-cause, cancer-related, and CVD-related mortality were estimated.
During a median follow-up of 7.0 years, 3177 deaths were recorded (including 1725 cancer deaths and 628 CVD deaths). Cox models with penalized splines showed U-shaped associations of unsweetened coffee, sugar-sweetened coffee, and artificially sweetened coffee with mortality. Compared with nonconsumers, consumers of various amounts of unsweetened coffee (>0 to 1.5, >1.5 to 2.5, >2.5 to 3.5, >3.5 to 4.5, and >4.5 drinks/d) had lower risks for all-cause mortality after adjustment for lifestyle, sociodemographic, and clinical factors, with respective hazard ratios of 0.79 (95% CI, 0.70 to 0.90), 0.84 (CI, 0.74 to 0.95), 0.71 (CI, 0.62 to 0.82), 0.71 (CI, 0.60 to 0.84), and 0.77 (CI, 0.65 to 0.91); the respective estimates for consumption of sugar-sweetened coffee were 0.91 (CI, 0.78 to 1.07), 0.69 (CI, 0.57 to 0.84), 0.72 (CI, 0.57 to 0.91), 0.79 (CI, 0.60 to 1.06), and 1.05 (CI, 0.82 to 1.36). The association between artificially sweetened coffee and mortality was less consistent. The association of coffee drinking with mortality from cancer and CVD was largely consistent with that with all-cause mortality. U-shaped associations were also observed for instant, ground, and decaffeinated coffee.
Exposure assessed at baseline might not capture changes in intake over time.
Moderate consumption of unsweetened and sugar-sweetened coffee was associated with lower risk for death.
National Natural Science Foundation of China, Young Elite Scientist Sponsorship Program by CAST, and Project Supported by Guangdong Basic and Applied Basic Research Foundation.
先前的观察性研究表明,咖啡摄入量与降低死亡风险之间存在关联,但这些研究并未区分加糖或人工甜味剂咖啡与无糖咖啡。
评估加糖、人工加糖和无加糖咖啡的消费与全因和特定原因死亡率的关系。
前瞻性队列研究。
数据从英国生物库中提取。
共有 171616 名(平均年龄 55.6 岁[SD,7.9])无心血管疾病(CVD)或癌症基线患者符合条件。使用英国生物库的基线人口统计学、生活方式和饮食数据,随访始于 2009 年,止于 2018 年。
加糖、人工加糖和无加糖咖啡的饮食摄入量由自我报告。估计全因、癌症相关和心血管疾病相关死亡率。
在中位随访 7.0 年期间,记录了 3177 例死亡(包括 1725 例癌症死亡和 628 例 CVD 死亡)。带有惩罚样条的 Cox 模型显示,无糖咖啡、加糖咖啡和人工加糖咖啡与死亡率呈 U 形关联。与非消费者相比,各种量的无糖咖啡(>0 至 1.5、>1.5 至 2.5、>2.5 至 3.5、>3.5 至 4.5 和>4.5 杯/天)在调整生活方式、社会人口统计学和临床因素后,全因死亡率风险降低,相应的危险比分别为 0.79(95%CI,0.70 至 0.90)、0.84(CI,0.74 至 0.95)、0.71(CI,0.62 至 0.82)、0.71(CI,0.60 至 0.84)和 0.77(CI,0.65 至 0.91);加糖咖啡的相应估计值分别为 0.91(CI,0.78 至 1.07)、0.69(CI,0.57 至 0.84)、0.72(CI,0.57 至 0.91)、0.79(CI,0.60 至 1.06)和 1.05(CI,0.82 至 1.36)。人工加糖咖啡与死亡率的关联不太一致。咖啡饮用与癌症和 CVD 死亡率之间的关联与全因死亡率的关联基本一致。速溶、研磨和脱咖啡因咖啡也观察到 U 形关联。
暴露情况在基线时评估,可能无法反映随时间的摄入变化。
适量饮用无糖和加糖咖啡与降低死亡风险有关。
国家自然科学基金、中国科学院青年创新促进会和广东省基础与应用基础研究基金项目。